Open AccessSurgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort
Author(s) -
Adam B. Weiner,
Jason Cohen,
John O.L. DeLancey,
Edward M. Schaeffer,
Gregory B. Auffenberg
Publication year - 2020
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000000684
Subject(s) - medicine , prostate cancer , castration , cohort , gynecology , urology , general surgery , cancer , hormone
Surgical castration for metastatic prostate cancer is used less frequently than medical castration yet costs less, requires less followup and may be associated with fewer adverse effects. We evaluated temporal trends and factors associated with the use of surgical castration.